For the effectiveness of bioactive ingredient targeting delivery in the gastrointestinal tract (GIT), the concanavalin A (Con A)-conjugated RSA film was developed for the potential bioadhesive coating material for colon-targeting bioadhesive microcapsules which were designed by the method of extrusion–spheronization and film coating process. The Con A-conjugated RSA films with coupled Con A from 8 to 32μg/mg showed sufficient higher storage modulus (G′) and glass transition temperature (Tg). The G′ and Tg increased as immersion in simulated digestive fluids progressed which allowed the films transformed from a viscoelastic state to a glassy state and is benefit for the bioactive ingredients releasing. Through adjusting the amount of coupled Con A the brittleness time and brittlement of Con A-conjugated RSA film could be adjusted and controlled for matching the colon targeting and releasing performance. The in-vitro and in-vivo study demonstrated that the Con A-conjugated RSA film coated microcapsules have good colon targeting and bioadhensive properties which could not only target bioactive molecules to the colon but also increase the residence time of the microcapsules for 72h in the colon.